@Article{,
AUTHOR = {David T. Marshall},
TITLE = {Options and recent advances in permanent brachytherapy for prostate cancer},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {14},
YEAR = {2007},
NUMBER = {Suppl.6},
PAGES = {28--31},
URL = {http://www.techscience.com/CJU/v14nSuppl.6/63317},
ISSN = {1488-5581},
ABSTRACT = {Permanent interstitial brachytherapy with I-125 or Pd-
103 seeds is a well-established approach as single modality
for low-risk prostate cancer patients and as part of a
multi-modality program for intermediate- and high-risk
patients. There are multiple approaches that have been
developed to deliver high-quality implants, including pre-planned and real-time intra-operative techniques. In the
hands of experienced users, either approach can provide
consistently excellent outcomes. We believe that the
combination of real-time intra-operative dosimetry and
connected seeds may provide for improved consistency
due to decreased seed migration.},
DOI = {}
}